Omicron may sideline two leading drugs against COVID-19
The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they’ve used to fight COVID-19
Stay updated with breaking news from James Cutrell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they’ve used to fight COVID-19
WASHINGTON (Associated Press) -- As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are...
WASHINGTON (AP) — As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.
The omicron variant of the coronavirus makes up nearly 3% of COVID-19 cases in the US. The CDC has detected the new strain in 43 states. Latest news.
The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they've used to fight COVID-19.